Multidisciplinary approach to the management of capecitabine-associated hand foot syndrome in cancer patients receiving capecitabine plus oxaliplatin and bevacizumab for advanced colorectal cancer

Hiroshi Matsuoka; Yoko Katagata; Hideki Ohta; Koutarou Maeda

doi:10.20407/fmj.3.1_1

Multidisciplinary approach to the management of capecitabine-associated hand foot syndrome in cancer patients receiving capecitabine plus oxaliplatin and bevacizumab for advanced colorectal cancer

Hiroshi Matsuoka, Yoko Katagata, Hideki Ohta, Koutarou Maeda

Gastrointestinal Surgery

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1-5
Number of pages	5
Journal	Fujita Medical Journal
Volume	3
Issue number	1
DOIs	https://doi.org/10.20407/fmj.3.1_1
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.20407/fmj.3.1_1

Cite this

@article{f82a653d3dbc42b7a4e2dbd07e3e38fc,

title = "Multidisciplinary approach to the management of capecitabine-associated hand foot syndrome in cancer patients receiving capecitabine plus oxaliplatin and bevacizumab for advanced colorectal cancer",

author = "Hiroshi Matsuoka and Yoko Katagata and Hideki Ohta and Koutarou Maeda",

year = "2017",

doi = "10.20407/fmj.3.1\_1",

language = "未定義/不明",

volume = "3",

pages = "1--5",

journal = "Fujita Medical Journal",

issn = "2189-7247",

publisher = "Fujita Medical Society",

number = "1",

}

Multidisciplinary approach to the management of capecitabine-associated hand foot syndrome in cancer patients receiving capecitabine plus oxaliplatin and bevacizumab for advanced colorectal cancer. / Matsuoka, Hiroshi; Katagata, Yoko; Ohta, Hideki et al.
In: Fujita Medical Journal, Vol. 3, No. 1, 2017, p. 1-5.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Multidisciplinary approach to the management of capecitabine-associated hand foot syndrome in cancer patients receiving capecitabine plus oxaliplatin and bevacizumab for advanced colorectal cancer

AU - Matsuoka, Hiroshi

AU - Katagata, Yoko

AU - Ohta, Hideki

AU - Maeda, Koutarou

PY - 2017

Y1 - 2017

U2 - 10.20407/fmj.3.1_1

DO - 10.20407/fmj.3.1_1

M3 - 学術論文

SN - 2189-7247

VL - 3

SP - 1

EP - 5

JO - Fujita Medical Journal

JF - Fujita Medical Journal

IS - 1

ER -